Early Versus Delayed Vitrectomy for Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy.
Anguita Rodrigo, Ferro Desideri Lorenzo, Schwember Philipp, Shah Neil, Ahmed Syed, Raharja Antony, Roth Janice, Sivaprasad Sobha, Wickham Louisa
AI Summary
Early vitrectomy for diabetic vitreous hemorrhage significantly improves 12-month vision and reduces complications, suggesting earlier intervention benefits long-term visual prognosis in these patients.
Abstract
Objective
To compare the clinical outcomes of early pars plana vitrectomy (PPV) versus delayed PPV in patients with first episode of vitreous hemorrhage (VH) secondary to proliferative diabetic retinopathy (PDR).
Design
Retrospective, comparative, interventional study.
Subjects, participants, and/or controls: Consecutive patients with type 1 or II diabetes diagnosed with new onset VH secondary to PDR who underwent PPV at Moorfields Eye Hospital between December 2014 and December 2016. Exclusions were prior vitrectomy, iris neovascularization, neovascular glaucoma, macular edema, or presence of tractional/rhegmatogenous retinal detachment.
Methods, intervention, or testing: Patients were divided into two groups based on the timing of their surgery: early PPV (≤6 weeks) and delayed PPV (>6 weeks). Demographic and clinical features, including best-corrected visual acuity (BCVA), expressed in logMAR at baseline and 12 months were collected. Statistical analyses, including propensity score matching, were performed using Python 3.10, Scikit-learn, Pandas, and GraphPad Prism 10.
Main outcome measures
BCVA at 12 months postoperatively, reoperation rates, and severity of complications.
Results
A total of 178 eyes were analyzed (48 early PPV, 130 delayed PPV). The mean (SD) number of weeks before surgery was 3.36 (SD 1.6) for the early PPV group and 22.56 (SD 17.23) for the delayed PPV group (P < .0001). Baseline BCVA prior to PPV was similar between groups (P = .08). At 12 months, the early PPV group had significantly better BCVA (0.40 logMAR vs 0.67 logMAR; P = .02). Patients without evidence of posterior vitreous detachment on ultrasound or OCT showed more pronounced differences (0.3 logMAR vs 0.7 logMAR; P = .001). The early PPV group had fewer sight-threatening complications (P = .005). Multivariable logistic regression identified initial BCVA, early PPV, and absence of preoperative panretinal photocoagulation as significant predictors of better visual outcomes.
Conclusions
Early PPV significantly improves visual outcomes and reduces severe complications in patients with VH secondary to PDR. These findings support the benefits of early surgical intervention to enhance long-term visual prognosis in these patients. However, a randomized clinical trial is warranted.
MeSH Terms
Shields Classification
Key Concepts4
Early pars plana vitrectomy (PPV) (surgery within ≤6 weeks) significantly improved best-corrected visual acuity (BCVA) at 12 months postoperatively (0.40 logMAR) compared to delayed PPV (surgery after >6 weeks) (0.67 logMAR) in patients with first episode of vitreous hemorrhage secondary to proliferative diabetic retinopathy (PDR) (P = .02).
Patients with first episode of vitreous hemorrhage secondary to proliferative diabetic retinopathy (PDR) who underwent early pars plana vitrectomy (PPV) (≤6 weeks) had fewer sight-threatening complications compared to those who underwent delayed PPV (>6 weeks) (P = .005).
In patients with first episode of vitreous hemorrhage secondary to proliferative diabetic retinopathy (PDR), multivariable logistic regression identified initial best-corrected visual acuity (BCVA), early pars plana vitrectomy (PPV), and absence of preoperative panretinal photocoagulation as significant predictors of better visual outcomes.
In patients with first episode of vitreous hemorrhage secondary to proliferative diabetic retinopathy (PDR) and without evidence of posterior vitreous detachment on ultrasound or OCT, early pars plana vitrectomy (PPV) (≤6 weeks) resulted in more pronounced differences in best-corrected visual acuity (BCVA) (0.3 logMAR) compared to delayed PPV (>6 weeks) (0.7 logMAR) at 12 months (P = .001).
Related Articles5
Clinicopathological features of severe corneal blood staining associated with proliferative diabetic retinopathy.
Case ReportIatrogenic ophthalmic artery occlusion and retinal artery occlusion.
Case SeriesBariatric surgery might aggravate proliferative diabetic retinopathy.
Observational StudyTerson syndrome: a case report suggesting the mechanism of vitreous hemorrhage.
Case ReportProcoagulant effects of intraocular sodium hyaluronate (Healon) after phakic diabetic vitrectomy. A prospective, randomized study.
Randomized Controlled TrialIs this article assigned to the wrong chapter(s)? Let us know.